Lantheus Holdings
NasdaqGM:LNTH Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 82 Fair Values set on narratives written by author
WA
Consensus Narrative from 13 Analysts
New CMS Rule Will Improve Medicare Access To PYLARIFY In 2025
Key Takeaways Strategic partnerships and market leadership in diagnostic radiopharmaceuticals drive revenue growth and enhance Medicare coverage opportunities. Expansion in Alzheimer's and prostate cancer diagnostics, along with royalties from out-licensed assets, support earnings growth and pipeline diversification.
View narrativeUS$134.69
FV
41.9% undervalued intrinsic discount10.37%
Revenue growth p.a.
3users have liked this narrative
0users have commented on this narrative
28users have followed this narrative
24 days ago author updated this narrative